001     154149
005     20240229123056.0
024 7 _ |a pmid:32187826
|2 pmid
024 7 _ |a 1715-4684
|2 ISSN
024 7 _ |a 1757-4676
|2 ISSN
024 7 _ |a 1757-4684
|2 ISSN
024 7 _ |a altmetric:77891436
|2 altmetric
024 7 _ |a 10.15252/emmm.201809271
|2 doi
037 _ _ |a DKFZ-2020-00610
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Hasan, Sana S
|0 P:(DE-HGF)0
|b 0
|e First author
245 _ _ |a Endothelial Notch signaling controls insulin transport in muscle.
260 _ _ |a Heidelberg
|c 2020
|b EMBO Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1610713366_28792
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:A270#LA:A270#2020 Apr 7;12(4):e09271
520 _ _ |a The role of the endothelium is not just limited to acting as an inert barrier for facilitating blood transport. Endothelial cells (ECs), through expression of a repertoire of angiocrine molecules, regulate metabolic demands in an organ-specific manner. Insulin flux across the endothelium to muscle cells is a rate-limiting process influencing insulin-mediated lowering of blood glucose. Here, we demonstrate that Notch signaling in ECs regulates insulin transport to muscle. Notch signaling activity was higher in ECs isolated from obese mice compared to non-obese. Sustained Notch signaling in ECs lowered insulin sensitivity and increased blood glucose levels. On the contrary, EC-specific inhibition of Notch signaling increased insulin sensitivity and improved glucose tolerance and glucose uptake in muscle in a high-fat diet-induced insulin resistance model. This was associated with increased transcription of Cav1, Cav2, and Cavin1, higher number of caveolae in ECs, and insulin uptake rates, as well as increased microvessel density. These data imply that Notch signaling in the endothelium actively controls insulin sensitivity and glucose homeostasis and may therefore represent a therapeutic target for diabetes.
536 _ _ |a 311 - Signalling pathways, cell and tumor biology (POF3-311)
|0 G:(DE-HGF)POF3-311
|c POF3-311
|f POF III
|x 0
588 _ _ |a Dataset connected to PubMed,
700 1 _ |a Jabs, Markus
|0 P:(DE-He78)91fcd65e6bc5ac8458df2a71d0d143d9
|b 1
|e First author
700 1 _ |a Taylor, Jacqueline
|0 P:(DE-He78)df29352b13734f9202e3b900aeef7754
|b 2
|u dkfz
700 1 _ |a Wiedmann, Lena
|0 P:(DE-He78)b27922c32bcdf07ca4d5f13ecdcfd100
|b 3
|u dkfz
700 1 _ |a Leibing, Thomas
|b 4
700 1 _ |a Nordström, Viola
|0 P:(DE-He78)9bce4efcbedb17d7b4d0d7832c136faf
|b 5
700 1 _ |a Federico, Giuseppina
|0 P:(DE-He78)616706c4d6f7bdf68b30893f860cbb2b
|b 6
700 1 _ |a Roma, Leticia P
|b 7
700 1 _ |a Carlein, Christopher
|b 8
700 1 _ |a Wolff, Gretchen
|b 9
700 1 _ |a Ekim-Üstünel, Bilgen
|b 10
700 1 _ |a Brune, Maik
|b 11
700 1 _ |a Moll, Iris
|0 P:(DE-He78)68d90eb013f51c689f9ebea83a920858
|b 12
|u dkfz
700 1 _ |a Tetzlaff, Fabian
|0 P:(DE-He78)2ccbbfe1b8852c4d003e0dde043a7f17
|b 13
700 1 _ |a Gröne, Hermann-Josef
|0 P:(DE-He78)00a2ea610aee4a8fca32908fc3d02e91
|b 14
700 1 _ |a Fleming, Thomas
|b 15
700 1 _ |a Géraud, Cyrill
|b 16
700 1 _ |a Herzig, Stephan
|b 17
700 1 _ |a Nawroth, Peter P
|0 0000-0002-6134-7804
|b 18
700 1 _ |a Fischer, Andreas
|0 P:(DE-He78)039283a5d51058ec79156d0ef67132da
|b 19
|e Last author
|u dkfz
773 _ _ |a 10.15252/emmm.201809271
|0 PERI:(DE-600)2485479-7
|n 4
|p e09271
|t EMBO molecular medicine
|v 12
|y 2020
|x 1757-4676
909 C O |p VDB
|o oai:inrepo02.dkfz.de:154149
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)91fcd65e6bc5ac8458df2a71d0d143d9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)df29352b13734f9202e3b900aeef7754
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)b27922c32bcdf07ca4d5f13ecdcfd100
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)9bce4efcbedb17d7b4d0d7832c136faf
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)616706c4d6f7bdf68b30893f860cbb2b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)68d90eb013f51c689f9ebea83a920858
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)2ccbbfe1b8852c4d003e0dde043a7f17
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)00a2ea610aee4a8fca32908fc3d02e91
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)039283a5d51058ec79156d0ef67132da
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-311
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Signalling pathways, cell and tumor biology
|x 0
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EMBO MOL MED : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b EMBO MOL MED : 2017
920 2 _ |0 I:(DE-He78)A270-20160331
|k A270
|l A270 Vaskuläre Signaltransduktion und Krebs
|x 0
920 0 _ |0 I:(DE-He78)A270-20160331
|k A270
|l A270 Vaskuläre Signaltransduktion und Krebs
|x 0
920 1 _ |0 I:(DE-He78)A270-20160331
|k A270
|l A270 Vaskuläre Signaltransduktion und Krebs
|x 0
920 1 _ |0 I:(DE-He78)G130-20160331
|k G130
|l G130 Zelluläre und Molekulare Pathologie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A270-20160331
980 _ _ |a I:(DE-He78)G130-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21